BlossomHill Therapeutics (BLSM) Stock Analysis
NASDAQHealthcareBiotechnology
What BlossomHill Therapeutics does
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Key metrics
ETFs linked to BLSM
Broad-market and Healthcare sector ETFs an investor holding BlossomHill Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BLSM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BLSM in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for BlossomHill Therapeutics?
- BlossomHill Therapeutics trades under the ticker BLSM on NASDAQ.
- Which exchange is BLSM listed on?
- BLSM is listed on NASDAQ.
- What sector does BlossomHill Therapeutics operate in?
- BlossomHill Therapeutics is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze BLSM in a portfolio?
- PortView shows BLSM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.